The data support the scalability of the strategy—still, an editorial urges that ethical concerns among the public can’t be ...

The US Food and Drug Administration has approved the Selution SLR sirolimus-eluting balloon for the treatment of coronary ...

HF with mildly reduced EF is gone, stages are updated, and new classifications for medical and interventional therapies are ...

Leaders call for removal of this outdated metric, which they say has no bearing over ongoing interventional cardiologist ...

Premature heart disease in men and women in this population stands out in a way that it doesn’t in other ethnic groups.

CRF ® is committed to igniting the next wave of innovation in research and education that will help docto ...

TCTMD's Todd Neale spoke with Warraich about the ADVOCATE program, which has its sights set on heart failure first.

Novartis announced that the phase III CV outcomes trial did not meet its primary endpoint, raising doubts over Lp(a)’s role.

Seamlessly merging the AHA’s new CV risk calculators into the country’s largest electronic health record system marks a big ...

Asymptomatic patients will now be covered and more flexibility has been given to heart teams for individualizing patient care ...

The guidelines introduce the “STAMP” acronym to help physicians in caring for patients with CKD: Screen, Triage, Address CKD ...

The latest UDMI aims to align classifications with pathology and clinical practice, bringing numerous changes to the 2018 ...